1 /15NR 565 Week 2 Study Questions
Chapters 1, 4, 13, 25, 52
1.Nurse practitioner prescriptive authority is regulated by
ANS The State Board of Nursing
2.The benefits to the patient of having an Advanced Practice Registered Nurse (APRN) prescriber include
ANS Nurses care for the patient from a holistic approach and include the patient in decision making regarding their care.
3.Clinical judgment in prescribing includes
ANS Factoring in the cost to the patient of the medication prescribed
4.Criteria for choosing an effective drug for a disorder include
ANS Consulting nationally recognized guidelines for disease management
5.Nurse practitioner practice may thrive under health-care reform
because of
ANS The demonstrated ability of nurse practitioners to control costs and improve patient outcomes
6.The U.S. Food and Drug Administration regulates 2 /15ANS The official labeling for all prescription and over-the-counter drugs
7.The U.S. Food and Drug Administration approval is required for
ANS Medical devices, including artificial joints
8.An Investigational New Drug is filed with the U.S. Food and Drug Adminis- tration
ANS Prior to human testing of any new drug entity
9.Phase IV clinical trials in the United States are also known as
ANS Postmarketing research
10.Off-label prescribing is
ANS Legal if there is scientific evidence for the use
11.The U.S. Drug Enforcement Administration
ANS Registers manufacturers and prescribers of controlled substances
12.Drugs that are designated Schedule II by the U.S. Drug Enforcement Ad- ministration
ANS May not be refilled; a new prescription must be written
13.Precautions that should be taken when prescribing controlled substances include
ANS Using tamper-proof paper for all prescriptions written for controlled
drugs
Chapters 1, 4, 13, 25, 52
1.Nurse practitioner prescriptive authority is regulated by
ANS The State Board of Nursing
2.The benefits to the patient of having an Advanced Practice Registered Nurse (APRN) prescriber include
ANS Nurses care for the patient from a holistic approach and include the patient in decision making regarding their care.
3.Clinical judgment in prescribing includes
ANS Factoring in the cost to the patient of the medication prescribed
4.Criteria for choosing an effective drug for a disorder include
ANS Consulting nationally recognized guidelines for disease management
5.Nurse practitioner practice may thrive under health-care reform
because of
ANS The demonstrated ability of nurse practitioners to control costs and improve patient outcomes
6.The U.S. Food and Drug Administration regulates 2 /15ANS The official labeling for all prescription and over-the-counter drugs
7.The U.S. Food and Drug Administration approval is required for
ANS Medical devices, including artificial joints
8.An Investigational New Drug is filed with the U.S. Food and Drug Adminis- tration
ANS Prior to human testing of any new drug entity
9.Phase IV clinical trials in the United States are also known as
ANS Postmarketing research
10.Off-label prescribing is
ANS Legal if there is scientific evidence for the use
11.The U.S. Drug Enforcement Administration
ANS Registers manufacturers and prescribers of controlled substances
12.Drugs that are designated Schedule II by the U.S. Drug Enforcement Ad- ministration
ANS May not be refilled; a new prescription must be written
13.Precautions that should be taken when prescribing controlled substances include
ANS Using tamper-proof paper for all prescriptions written for controlled
drugs
